Adaptive Biotechnologies (ADPT) Net Income towards Common Stockholders (QoQ) (2018 - 2026)
Adaptive Biotechnologies (ADPT) Net Income towards Common Stockholders (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Adaptive Biotechnologies | 2.66 Bn | 2.45 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.40% |
| Dec 31, 2025 | -242.26% |
| Sep 30, 2025 | 137.30% |
| Jun 30, 2025 | 14.20% |
| Mar 31, 2025 | 11.53% |
| Dec 31, 2024 | -5.05% |
| Sep 30, 2024 | 30.60% |
| Jun 30, 2024 | 2.70% |
| Mar 31, 2024 | 31.57% |
| Dec 31, 2023 | -38.03% |
| Sep 30, 2023 | -5.26% |
| Jun 30, 2023 | 17.14% |
| Mar 31, 2023 | -43.64% |
| Dec 31, 2022 | 11.36% |
| Sep 30, 2022 | 12.99% |
| Jun 30, 2022 | 17.06% |
| Mar 31, 2022 | -2.35% |
| Dec 31, 2021 | -9.57% |
| Sep 30, 2021 | -13.58% |
| Jun 30, 2021 | -21.31% |